Navneet Momi, Ph.D. - Publications

Affiliations: 
2012 Biochemistry and Molecular Biology University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Biochemistry, Molecular Biology, Oncology, Cell Biology

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Cruz MD, Ledbetter S, Chowdhury S, Tiwari AK, Momi N, Wali RK, Bliss C, Huang C, Lichtenstein D, Bhattacharya S, Varma-Wilson A, Backman V, Roy HK. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis. Oncotarget. 8: 20543-20557. PMID 28423551 DOI: 10.18632/Oncotarget.16129  0.38
2017 Zhang M, Cruz MD, Momi N, Chowdhury S, Roy H, Lerner A. Abstract 2562: Stromal antigen 1 (SA1) as a potential pro-neoplastic factor in non-small-cell lung cancer (NSCLC) Cancer Research. 77: 2562-2562. DOI: 10.1158/1538-7445.Am2017-2562  0.324
2017 DeLa Cruz M, Momi N, Datta S, Chowdhury S, Roy HK. SA1 and Colorectal Cancer: Biomarker for Obesity-Driven CRC Carcinogenesis Gastroenterology. 152: S1025. DOI: 10.1016/S0016-5085(17)33470-4  0.349
2016 Wali RK, Momi N, Dela Cruz M, Calderwood AH, Stypula Y, Almassalha LM, Chhaparia A, Weber CR, Radosevich A, Tiwari AK, Latif B, Backman V, Roy HK. Higher-Order Chromatin Modulator Cohesin SA1 is an Early Biomarker for Colon Carcinogenesis: Race-Specific Implications. Cancer Prevention Research (Philadelphia, Pa.). PMID 27549371 DOI: 10.1158/1940-6207.Capr-16-0054  0.378
2016 Momi N, Brendler CB, Roy HK. Abstract B04: Cohesin complex subunit (stromal antigen1): Potential molecular determinant of racial disparities in prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B04  0.351
2016 DeLaCruz M, Ohm JT, Ledbetter SE, Momi N, Chhaparia A, Yadav A, Wali RK, Roy HK. Su2057 Towards Identification of Factors In Exercise-Induced Colorectal Cancer Prevention: Development of a Novel Cell Culture Model Gastroenterology. 150: S623. DOI: 10.1016/S0016-5085(16)32139-4  0.359
2016 DeLaCruz M, Ohm JT, Latif B, Calderwood AH, Momi N, Ledbetter SE, Roy HK. Su2027 Mitochondrial Dysregulation in Premalignant Colonic Epithelium: Evidence of the Warburg Effect During Initiation of Colorectal Carcinogenesis Gastroenterology. 150: S615. DOI: 10.1016/S0016-5085(16)32109-6  0.306
2016 Momi N, Wali RK, Chhaparia A, Calderwood AH, Tiwari AK, Ledbetter SE, DeLaCruz M, Roy HK. Su2000 PRDM16 is a Novel Proto-Oncogene in Colorectal Cancer (CRC): Modulation of the Early Warburg Effect in Field Carcinogenesis Gastroenterology. 150: S606. DOI: 10.1016/S0016-5085(16)32082-0  0.388
2015 Kumar S, Torres MP, Kaur S, Rachagani S, Joshi S, Johansson SL, Momi N, Baine MJ, Gilling CE, Smith LM, Wyatt TA, Jain M, Joshi SS, Batra SK. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Oncogene. 34: 2052-60. PMID 24909166 DOI: 10.1038/Onc.2014.154  0.641
2015 Roy HK, DelaCruz M, Wali R, Momi N, Chhaparia A, Parker B. Downregulation of Novel Tumor Suppressor Gene SA-1 in Early Colon Carcinogenesis Has a Predilection for Blacks: Potential Biological Underpinnings for Colorectal Cancer (CRC) Disparities American Journal of Gastroenterology. 110: S586. DOI: 10.14309/00000434-201510001-01350  0.381
2015 Momi N, Hou L, Wali RK, Zhang W, Chhaparia A, Weber CR, DeLaCruz M, Roy HK. Sa1960 Novel Epigenetic: Metabolic Axis in Early Colon Carcinogenesis and NSAIDs Resistance: Potential Role of Adipogenic Regulator PRDM16 Gastroenterology. 148: S-368. DOI: 10.1016/S0016-5085(15)31233-6  0.32
2015 DeLaCruz M, Chhaparia A, Momi N, Wali RK, Roy HK. Sa1952 Unraveling the Mechanisms Involved in Exercise Prevention of Colorectal Cancer: The Role of Skeletal Muscles Gastroenterology. 148: S-365. DOI: 10.1016/S0016-5085(15)31225-7  0.327
2015 DeLaCruz M, Latif B, Chhaparia A, Momi N, Wali RK, Roy HK. Sa1911 Mitochondrial Alterations in Early Colon Carcinogenesis: Evidence for Warburg Effect in the Initiation of Colorectal Cancer (CRC) Carcinogenesis Gastroenterology. 148: S-353. DOI: 10.1016/S0016-5085(15)31185-9  0.362
2014 Cruz MD, Wali RK, Bianchi LK, Radosevich AJ, Crawford SE, Jepeal L, Goldberg MJ, Weinstein J, Momi N, Roy P, Calderwood AH, Backman V, Roy HK. Colonic mucosal fatty acid synthase as an early biomarker for colorectal neoplasia: modulation by obesity and gender. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2413-21. PMID 25155760 DOI: 10.1158/1055-9965.Epi-14-0026  0.339
2014 Kaur S, Momi N, Chakraborty S, Wagner DG, Horn AJ, Lele SM, Theodorescu D, Batra SK. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis. Plos One. 9: e92742. PMID 24671186 DOI: 10.1371/Journal.Pone.0092742  0.462
2014 Momi N, Kaur S, Rachagani S, Ganti AK, Batra SK. Smoking and microRNA dysregulation: a cancerous combination. Trends in Molecular Medicine. 20: 36-47. PMID 24238736 DOI: 10.1016/J.Molmed.2013.10.005  0.499
2014 DeLaCruz M, Weinstein J, Calderwood A, Wali R, Momi N, Roy H. Discordant Regulation of Colonic Mucosal Fatty Acid Synthase (FASN) in African Americans and Caucasians: Implications for Colorectal Cancer Disparities American Journal of Gastroenterology. 109: S616. DOI: 10.14309/00000434-201410002-02098  0.366
2014 Chitsaz E, DeLaCruz M, Calderwood A, Wali R, Momi N, Weinstein J, Davis A, Roy H. Differential Expression of Cohesin SA in Early Colorectal Carcinogenesis: Potential Biomarker for Racial Disparities American Journal of Gastroenterology. 109: S612. DOI: 10.14309/00000434-201410002-02081  0.337
2014 Momi N, Subramanian H, Bowen L, DeLaCruz M, Weinstein J, Wali RK, Backman V, Roy HK. Sa1374 Paracrine Signaling Between Pancreatic Cancer and Small Intestinal Cells As the Biological Underpinnings of Duodenal Alterations in Field Carcinogenesis: Implications for Screening Gastroenterology. 146: S-277. DOI: 10.1016/S0016-5085(14)60976-8  0.404
2014 DeLaCruz M, Wali RK, Weinstein J, Goldberg MJ, Bianchi LK, Bajaj S, Momi N, Roy HK. 1022 Targeting Fatty Acid Synthase (FASN) As a Modality to Ameliorate Obesity Related Colorectal Cancer (CRC) Gastroenterology. 146: S-180. DOI: 10.1016/S0016-5085(14)60641-7  0.303
2013 Kaur S, Kumar S, Momi N, Sasson AR, Batra SK. Mucins in pancreatic cancer and its microenvironment. Nature Reviews. Gastroenterology & Hepatology. 10: 607-20. PMID 23856888 DOI: 10.1038/Nrgastro.2013.120  0.552
2013 Momi N, Ponnusamy MP, Kaur S, Rachagani S, Kunigal SS, Chellappan S, Ouellette MM, Batra SK. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Oncogene. 32: 1384-95. PMID 22614008 DOI: 10.1038/Onc.2012.163  0.537
2012 Momi N, Kaur S, Krishn SR, Batra SK. Discovering the route from inflammation to pancreatic cancer. Minerva Gastroenterologica E Dietologica. 58: 283-97. PMID 23207606  0.454
2012 Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, Batra SK. Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis. Carcinogenesis. 33: 1617-28. PMID 22623649 DOI: 10.1093/Carcin/Bgs186  0.531
2012 Kunigal S, Ponnusamy MP, Momi N, Batra SK, Chellappan SP. Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades. Molecular Cancer. 11: 24. PMID 22537161 DOI: 10.1186/1476-4598-11-24  0.571
2012 Wittel UA, Momi N, Seifert G, Wiech T, Hopt UT, Batra SK. The pathobiological impact of cigarette smoke on pancreatic cancer development (review). International Journal of Oncology. 41: 5-14. PMID 22446714 DOI: 10.3892/Ijo.2012.1414  0.554
2012 Senapati S, Gnanapragassam VS, Moniaux N, Momi N, Batra SK. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. Oncogene. 31: 3346-56. PMID 22105367 DOI: 10.1038/Onc.2011.505  0.486
2010 Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Letters. 295: 69-84. PMID 20303649 DOI: 10.1016/J.Canlet.2010.02.015  0.506
2010 Momi N, Ponnusamy MP, Batra SK. Abstract 431: Cigarette-smoke-induced expression of MUC4 in human pancreatic cancer cells: Potential pathological roles Cancer Research. 70: 431-431. DOI: 10.1158/1538-7445.Am10-431  0.566
2009 Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. British Journal of Cancer. 101: 1155-61. PMID 19738614 DOI: 10.1038/Sj.Bjc.6605285  0.659
Show low-probability matches.